Cardax Reports Q3 2018 Results

Author's Avatar
Nov 14, 2018
Article's Main Image

Robust ZanthoSyn® Sales Growth Continues

- 102% Greater Than Q2 2018

- 71% Greater Than Q3 2017

- 129% 9-Month Sales Growth

PR Newswire